IS7287A - Pýrimídín efnasambönd - Google Patents
Pýrimídín efnasamböndInfo
- Publication number
- IS7287A IS7287A IS7287A IS7287A IS7287A IS 7287 A IS7287 A IS 7287A IS 7287 A IS7287 A IS 7287A IS 7287 A IS7287 A IS 7287A IS 7287 A IS7287 A IS 7287A
- Authority
- IS
- Iceland
- Prior art keywords
- pyrimidine compounds
- pyrimidine
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/000,742 US6693097B2 (en) | 2001-11-30 | 2001-11-30 | Pyrimidine compounds |
| US10/192,347 US6660733B2 (en) | 2001-11-30 | 2002-07-10 | 2,4,6-trisubstituted-pyrimidine compounds |
| PCT/US2002/038161 WO2003047516A2 (en) | 2001-11-30 | 2002-11-27 | Pyrimidine compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS7287A true IS7287A (is) | 2004-05-26 |
Family
ID=26668093
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS7287A IS7287A (is) | 2001-11-30 | 2004-05-26 | Pýrimídín efnasambönd |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US6958332B2 (is) |
| EP (1) | EP1458687B1 (is) |
| JP (1) | JP2005519034A (is) |
| KR (1) | KR100950122B1 (is) |
| CN (1) | CN100349876C (is) |
| AU (1) | AU2002357033B2 (is) |
| BR (1) | BR0214809A (is) |
| CA (1) | CA2468349A1 (is) |
| IL (1) | IL162189A0 (is) |
| IS (1) | IS7287A (is) |
| MX (1) | MXPA04005181A (is) |
| NO (1) | NO328144B1 (is) |
| NZ (1) | NZ533437A (is) |
| RU (1) | RU2320658C2 (is) |
| TW (1) | TWI256953B (is) |
| WO (1) | WO2003047516A2 (is) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2468349A1 (en) * | 2001-11-30 | 2003-06-12 | Synta Pharmaceuticals Corporation | Pyrimidine compounds |
| US6693097B2 (en) * | 2001-11-30 | 2004-02-17 | Synta Pharmaceuticals Corp. | Pyrimidine compounds |
| AU2003284142A1 (en) * | 2002-10-15 | 2004-05-04 | Synta Pharmaceuticals Corp | Aromatic bicyclic heterocyles to modulate 1L-12 production |
| WO2005046619A2 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Compositions and methods for modulating c-rel-dependent cytokine production |
| EP1689403A4 (en) * | 2003-11-10 | 2007-09-05 | Synta Pharmaceuticals Corp | HETEROARYL-hydrazone compounds |
| CA2545258A1 (en) * | 2003-11-10 | 2005-05-26 | Synta Pharmaceuticals, Corp. | Pyridine compounds |
| EP1687002A4 (en) * | 2003-11-10 | 2008-07-23 | Synta Pharmaceuticals Corp | CONDENSED HETEROCYCLIC COMPOUNDS |
| TWI380816B (zh) * | 2004-04-13 | 2013-01-01 | Synta Pharmaceuticals Corp | 抑制介白素-１２（ｉｌ-１２）生成之二鹽抑制劑 |
| AU2005262322B2 (en) * | 2004-07-01 | 2012-07-26 | Synta Pharmaceuticals Corp. | 2-substituted heteroaryl compounds |
| AU2005284904A1 (en) | 2004-09-13 | 2006-03-23 | Amgen Inc. | Vanilloid receptor ligands and their use in treatments |
| WO2006053112A1 (en) * | 2004-11-10 | 2006-05-18 | Synta Pharmaceuticals Corp. | Process for preparing trisubstituted pyrimidine compounds |
| TW200628463A (en) * | 2004-11-10 | 2006-08-16 | Synta Pharmaceuticals Corp | Heteroaryl compounds |
| AU2005304393B2 (en) * | 2004-11-10 | 2012-09-27 | Synta Pharmaceuticals Corp. | IL-12 modulatory compounds |
| CA2587590A1 (en) * | 2004-11-19 | 2006-06-08 | Synta Pharmaceuticals Corp. | Pyrimidine compounds and uses thereof |
| US20070032493A1 (en) * | 2005-05-26 | 2007-02-08 | Synta Pharmaceuticals Corp. | Method for treating B cell regulated autoimmune disorders |
| TW200804307A (en) * | 2005-10-27 | 2008-01-16 | Synta Pharmaceuticals Corp | Process for preparing mesylate salts of IL-12 inhibitory compounds |
| WO2007065940A1 (en) * | 2005-12-08 | 2007-06-14 | Laboratoires Serono S.A. | Antiproliferative pyrimidyl, fused pyrimidyl and pyrimidyl hydrazones |
| WO2008110891A2 (en) * | 2007-03-09 | 2008-09-18 | Orchid Research Laboratories Limited, | New heterocyclic compounds |
| WO2009100406A2 (en) * | 2008-02-07 | 2009-08-13 | Synta Pharmaceuticals Corp. | Topical formulations for the treatment of psoriasis |
| PL2254869T3 (pl) | 2008-03-07 | 2017-10-31 | Acraf | Nowe pochodne 1-benzylo-3-hydroksymetyloindazolu i ich zastosowanie w leczeniu chorób bazujących na ekspresji CX3CR1 i p40 |
| PL2262778T3 (pl) | 2008-03-07 | 2020-02-28 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Pochodne 1-benzylo-3-hydroksymetyloindazolu i ich zastosowanie w leczeniu chorób opartych na ekspresji MCP-1, CXCR1 i p40 |
| WO2010074284A1 (ja) | 2008-12-26 | 2010-07-01 | 味の素株式会社 | ピラゾロピリミジン化合物 |
| EP2518072A4 (en) | 2009-12-24 | 2014-06-04 | Ajinomoto Kk | IMIDAZOPYRIDAZINE COMPOUNDS |
| PT2595965T (pt) * | 2010-07-20 | 2016-08-22 | Vestaron Corp | Triazinas e pirimidinas inseticidas |
| CN105963300B (zh) * | 2015-03-13 | 2019-06-11 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | PIKfyve抑制剂抗辐射损伤的用途 |
| CN106279041A (zh) * | 2016-08-16 | 2017-01-04 | 四川思睿博生物科技有限公司 | 苯基嘧啶衍生物及其制备方法和用途 |
| AU2019223014B2 (en) | 2018-02-21 | 2024-10-17 | AI Therapeutics, Inc. | Combination therapy with apilimod and glutamatergic agents |
| CN118488831A (zh) | 2021-12-23 | 2024-08-13 | 苏宾特罗有限公司 | 包含油酸的新抗病毒组合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6830751B1 (en) | 1994-03-14 | 2004-12-14 | Genetics Institute, Llc | Use of IL-12 antagonists in the treatment of rheumatoid arthritis |
| GB9905075D0 (en) * | 1999-03-06 | 1999-04-28 | Zeneca Ltd | Chemical compounds |
| PT1169038E (pt) * | 1999-04-15 | 2012-10-26 | Bristol Myers Squibb Co | Inibidores cíclicos da proteína tirosina cinase |
| US6384032B1 (en) * | 1999-06-17 | 2002-05-07 | Shionogi Bioresearch Corp. | Inhibitors of IL-12 production |
| AU2735201A (en) * | 1999-12-28 | 2001-07-09 | Pharmacopeia, Inc. | Pyrimidine and triazine kinase inhibitors |
| US6525051B2 (en) * | 2000-03-27 | 2003-02-25 | Schering Aktiengesellschaft | N-heterocyclic derivatives as NOS inhibitors |
| US6680315B2 (en) | 2000-06-15 | 2004-01-20 | Synta Pharmaceuticals Corp. | Triazine compounds |
| US6693097B2 (en) | 2001-11-30 | 2004-02-17 | Synta Pharmaceuticals Corp. | Pyrimidine compounds |
| CA2468349A1 (en) | 2001-11-30 | 2003-06-12 | Synta Pharmaceuticals Corporation | Pyrimidine compounds |
| EP1689403A4 (en) | 2003-11-10 | 2007-09-05 | Synta Pharmaceuticals Corp | HETEROARYL-hydrazone compounds |
-
2002
- 2002-11-27 CA CA002468349A patent/CA2468349A1/en not_active Abandoned
- 2002-11-27 KR KR1020047008313A patent/KR100950122B1/ko not_active IP Right Cessation
- 2002-11-27 IL IL16218902A patent/IL162189A0/xx unknown
- 2002-11-27 BR BR0214809-9A patent/BR0214809A/pt not_active IP Right Cessation
- 2002-11-27 NZ NZ533437A patent/NZ533437A/en not_active IP Right Cessation
- 2002-11-27 RU RU2004119853/04A patent/RU2320658C2/ru active IP Right Revival
- 2002-11-27 WO PCT/US2002/038161 patent/WO2003047516A2/en active Application Filing
- 2002-11-27 EP EP02804468A patent/EP1458687B1/en not_active Expired - Lifetime
- 2002-11-27 CN CNB028239512A patent/CN100349876C/zh not_active Expired - Lifetime
- 2002-11-27 AU AU2002357033A patent/AU2002357033B2/en not_active Ceased
- 2002-11-27 JP JP2003548777A patent/JP2005519034A/ja not_active Withdrawn
- 2002-11-27 MX MXPA04005181A patent/MXPA04005181A/es active IP Right Grant
- 2002-11-29 TW TW091134807A patent/TWI256953B/zh not_active IP Right Cessation
-
2003
- 2003-09-05 US US10/655,672 patent/US6958332B2/en not_active Expired - Lifetime
-
2004
- 2004-05-26 IS IS7287A patent/IS7287A/is unknown
- 2004-06-29 NO NO20042742A patent/NO328144B1/no not_active IP Right Cessation
-
2005
- 2005-07-29 US US11/193,002 patent/US7470681B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR100950122B1 (ko) | 2010-03-30 |
| CA2468349A1 (en) | 2003-06-12 |
| US7470681B2 (en) | 2008-12-30 |
| TW200400190A (en) | 2004-01-01 |
| US6958332B2 (en) | 2005-10-25 |
| EP1458687A4 (en) | 2005-03-23 |
| KR20050058257A (ko) | 2005-06-16 |
| TWI256953B (en) | 2006-06-21 |
| IL162189A0 (en) | 2005-11-20 |
| CN1599726A (zh) | 2005-03-23 |
| RU2004119853A (ru) | 2006-01-10 |
| AU2002357033B2 (en) | 2009-05-07 |
| MXPA04005181A (es) | 2005-06-17 |
| JP2005519034A (ja) | 2005-06-30 |
| AU2002357033A1 (en) | 2003-06-17 |
| US20060030560A1 (en) | 2006-02-09 |
| NO328144B1 (no) | 2009-12-14 |
| EP1458687B1 (en) | 2012-01-11 |
| US20040053937A1 (en) | 2004-03-18 |
| CN100349876C (zh) | 2007-11-21 |
| NZ533437A (en) | 2007-05-31 |
| RU2320658C2 (ru) | 2008-03-27 |
| NO20042742L (no) | 2004-08-24 |
| WO2003047516A3 (en) | 2003-07-31 |
| BR0214809A (pt) | 2004-09-14 |
| EP1458687A2 (en) | 2004-09-22 |
| WO2003047516A2 (en) | 2003-06-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2015035I1 (el) | Ενωσεις πυριμιδινης | |
| NO20024127D0 (no) | Pyrimidin-forbindelser | |
| IS7287A (is) | Pýrimídín efnasambönd | |
| DK1419152T3 (da) | HIV-hæmmende pyrimidin-derivater | |
| IS6971A (is) | Ný efnasambönd | |
| DK1303496T3 (da) | Pyrimidinderivater | |
| ATE402148T1 (de) | Substituierte pyridinylamine | |
| IS6868A (is) | Ný pýrimidínefnasambönd | |
| DE50206892D1 (de) | Substituierte imidazotriazinone | |
| NO20032291D0 (no) | Pyrimidinderivater | |
| ATE435197T1 (de) | Substituierte 4-aminocyclohexanole | |
| DE60216967D1 (de) | Substituierte cyclohexanderivate | |
| SE0100272D0 (sv) | New compounds | |
| SE0104342D0 (sv) | New compounds | |
| SE0103461D0 (sv) | New compounds | |
| SE0103437D0 (sv) | New compounds | |
| SE0102386D0 (sv) | New compounds | |
| SE0101660D0 (sv) | New compounds | |
| SE0101659D0 (sv) | New compounds | |
| SE0100629D0 (sv) | New compounds | |
| SE0104366D0 (sv) | New compounds | |
| SE0101958D0 (sv) | New compounds | |
| SE0102056D0 (sv) | New Compounds | |
| SE0102807D0 (sv) | Novel compounds | |
| SE0100641D0 (sv) | Novel compounds |